{"version":"1.0","type":"link","title":"Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion.","author_name":"Abdulkareem NM 외","author_url":"https://prs-insight.online/author/Abdulkareem%20NM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76009","thumbnail_width":1200,"thumbnail_height":630}